BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Post-Approval (World)
Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu" 4/14/2014  More...
FDA Grants Breakthrough Status Designation To Novartis AG (NVS)' Meningitis B Vaccine 4/8/2014  More...
H. Lundbeck A/S (LUN.CO) Release: Treatment With Once-Monthly Abilify Maintena® (Aripiprazole) Significantly Reduces Hospitalisation Rates For Patients With Schizophrenia Compared With Daily Oral Antipsychotics 4/7/2014  More...
Roche (RHHBY)-Backed Study Finds Tamiflu Saved Lives In Flu Pandemic 3/19/2014  More...
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014  More...
Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy 3/4/2014  More...
Baxter International, Inc. (BAX) Presents Data At EAHAD From Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience With ADVATE 2/27/2014  More...
Roche (RHHBY) May Share Avastin Brain Cancer Data Amid Conflicting Results 2/21/2014  More...
Ranbaxy Laboratories (RANBAXY.BO) Workers Fudged Test Results: FDA 1/28/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Data Demonstrates Key Genes Respond Differently To COPAXONE® (glatiramer acetate injection) Versus A Purported Generic Glatiramer Acetate 1/13/2014  More...
German Watchdog Deals Setback To Bayer AG (BAYN.DE) Eye Drug Eylea 1/6/2014  More...
AstraZeneca PLC (AZN)'s Arimidex Halves Breast Cancer Risk, Study Finds 12/12/2013  More...
Lundbeck Inc. (LUN.CO) Release: New Study Showed Improvement In Cognitive Performance In Adult Patients Treated With Brintellix® (Vortioxetine) For Acute Episodes Of Major Depression 12/11/2013  More...
Zealand Pharma  (ZEAL.CO) Informs That New Data Presented At The World Diabetes Congress Support Flexibility In Timing Of Administration For Lyxumia® 12/5/2013  More...
Janssen Pharmaceutica N.V. Unveils New Data On Xeplion® In Various Stages Of Schizophrenia 12/2/2013  More...
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) 150mg Bid Continues To Be The Only Oral Anticoagulant Which Showed Superior Ischaemic Stroke Reduction Vs. Warfarin In Its Pivotal Study RE-LY® 11/25/2013  More...
Boehringer Ingelheim Corporation Planning Two New Global Clinical Trials For Pradaxa® (Dabigatran Etexilate) In Expanded Patient Populations 11/19/2013  More...
First Human Data Show Promise Of Boehringer Ingelheim Corporation’s Specific Antidote For Immediate, Complete And Sustained Reversal Of Pradaxa®-Induced Anticoagulation 11/18/2013  More...
EU Agency Questions AstraZeneca PLC (AZN) Over Heart Drug Trial 11/8/2013  More...
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study 11/5/2013  More...
Roche (RHHBY)'s Avastin Boosts Survival in Advanced Ovarian Cancer 10/23/2013  More...
Novo Nordisk A/S (NVO) Study Shows Tresiba Efficacy for Diabetes 9/26/2013  More...
Data Show Sanofi (France) (SAN.PA)'s Lyxumia® Added to Basal Insulin Lowered Blood Sugar Especially When Fasting Plasma Glucose Was Controlled 9/24/2013  More...
Roche (RHHBY)'s Perjeta Works in Early-Stage Breast Cancer 9/11/2013  More...
Boehringer Ingelheim GmbH's Respimat Inhaler Meets Safety Goal in Study 9/3/2013  More...
FDA Probes Brain Infection in Patient on Novartis AG (NVS)'s MS Drug 9/3/2013  More...
Novartis AG (NVS)'s Afinitor® Fails Phase 3 Liver Cancer Trial 8/8/2013  More...
Orexo AB: First Patient Dosed in New Study on Long-Term Adherence to Treatment of Opioid Dependence With Zubsolv® 8/7/2013  More...
Deja Vu: Second Probe Finds Manipulated Trial Data for Novartis AG (NVS) Drug 8/5/2013  More...
Celgene International Sárl (CELG) Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine 8/1/2013  More...
European Medicines Agency Approves SmPC Change to Baxter International, Inc. (BAX)’s ADVATE to Include Information on PK-Guided Dosing Study 7/22/2013  More...
Roche (RHHBY)'s Avastin as Good as Novartis AG (NVS)'s Lucentis for AMD 7/19/2013  More...
Boehringer Ingelheim Corporation Release: Benefits of Pradaxa® Maintained in Difficult to Treat Patients With Atrial Fibrillation and Symptomatic Heart Failure 7/16/2013  More...
Novartis AG (NVS) Drug Study Data Manipulated: Kyoto Prefectrual University of Medicine 7/16/2013  More...
Baxter International, Inc. (BAX) Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients 7/8/2013  More...
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF 6/17/2013  More...
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease 6/17/2013  More...
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer 6/14/2013  More...
AbbVie (ABBV) Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis 6/13/2013  More...
Bristol-Myers Squibb Company (BMY)'s Orencia Matches Abbott Laboratories (ABT)' Humira in Arthritis Study 6/12/2013  More...
Merck & Co., Inc. (MRK) Joins Novo Nordisk A/S (NVO) to Reassure Safety of Diabetes Drugs 6/12/2013  More...
Sanofi (France) (SAN.PA) Steps Up Diabetes Drive as Rivals Raise the Stakes 6/10/2013  More...
Eisai Company, Ltd. (ESALY.PK) Confirms Therapeutic Effects of Lenvatinib in Patients With Melanoma in Strategic Collaboration With Quintiles, Inc. (Q) to Develop Eisai Anticancer Compounds 6/10/2013  More...
New Bird Flu Found to be Resistant to Roche (RHHBY)'s Tamiflu 5/30/2013  More...
Boehringer Ingelheim Corporation Release: New European Survey Highlights Ischaemic Stroke Protection as Treatment Priority for Patients With Atrial Fibrillation 5/28/2013  More...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1 5/21/2013  More...
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop 5/21/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Parkinson's Treatment Meets Study Goals 3/20/2013  More...
German Cost Regulator Rejects Bayer AG (BAY.F) and Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug 3/20/2013  More...
EU Expands Use of Roche (RHHBY)'s Pegasys in Chronic Hepatitis C 3/18/2013  More...
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists 3/18/2013  More...
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013  More...
Serious Side Effects Seen With Failed Merck & Co., Inc. (MRK) Niacin Drug 3/11/2013  More...
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study 3/8/2013  More...
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma 3/7/2013  More...
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism 2/21/2013  More...
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix 1/24/2013  More...
Novartis AG (NVS) Says Afinitor Reduces Tumors in Rare Genetic Disease 1/11/2013  More...
Merck & Co., Inc. (MRK)'s Tredaptive is Under Review by European Medicines Agency After Failed Trial 12/26/2012  More...
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS 12/13/2012  More...
Novo Nordisk A/S (NVO) Bets on Turning Victoza Into Obesity Blockbuster 12/12/2012  More...
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting 12/11/2012  More...
Genentech (RHHBY)'s Perjeta Extends Life of Breast Cancer Patients by 34 Pct 12/11/2012  More...
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia 12/11/2012  More...
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin 12/10/2012  More...
GlaxoSmithKline (GSK): We Conducted Paxil Clinical Trial Program Appropriately 12/7/2012  More...
AstraZeneca PLC (AZN) Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2 12/5/2012  More...
Eli Lilly and Company (LLY)'s ED Drug, Cialis, Shows Promise in Rare Muscle Disease 11/30/2012  More...
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal 11/28/2012  More...
Novo Nordisk A/S (NVO) Says New Data Show Victoza Advantage 11/27/2012  More...
Roche (RHHBY)'s Avastin Shows Mixed Results in Glioblastoma 11/23/2012  More...
Gilead Sciences, Inc. (GILD)'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients 11/15/2012  More...
Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients 11/15/2012  More...
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes 11/8/2012  More...
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF 11/8/2012  More...
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement 11/6/2012  More...
Novartis AG (NVS) Drug Works to Treat Rare Cushing's Disease 11/6/2012  More...
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation 11/5/2012  More...
GlaxoSmithKline (GSK), Roche (RHHBY) Drugs Help Treat Breast Cancer in Brain 11/2/2012  More...
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH's Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions 10/31/2012  More...
Novartis AG (NVS) Cannibalizes Gleevec to Boost New Cancer Drug 10/29/2012  More...
Sleep Tight: GlaxoSmithKline (GSK) Vaccine Not Linked To Narcolepsy 10/19/2012  More...
Eisai Company, Ltd. (ESALY.PK)'s Epilepsy Drug Helps Obese Patients Lose Weight 10/17/2012  More...
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Makes Progress With MS Drugs 10/15/2012  More...
Novartis AG (NVS)'s Gilenya Cuts Early Relapse, Brain Loss in MS Patients 10/12/2012  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People With Relapsing Forms of MS 10/11/2012  More...
Sanofi (France) (SAN.PA) Says Zaltrap Cancer Drug Study Positive 10/9/2012  More...
Sanofi (France) (SAN.PA) Flags Positive Study on Lantus Insulin 10/5/2012  More...
Cancer Trials Show One Year on Roche (RHHBY)'s Herceptin is Best 10/1/2012  More...
Celgene (CELG)'s Abraxane is Talk of Cancer Meeting 10/1/2012  More...
New Janssen Pharmaceutica N.V. Data Demonstrate STELARA® (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients With Moderate to Severe Plaque Psoriasis 9/28/2012  More...
Boehringer Ingelheim GmbH Release: Asian Populations With Atrial Fibrillation (AF) Benefit From Better Stroke Prevention With Pradaxa® (dabigatran etexilate) Compared to Warfarin 9/12/2012  More...
New Data Confirms Safety of Novartis AG (NVS)'s Eye Drug Lucentis 9/5/2012  More...
Novartis AG (NVS) Smoker's Cough Treatment Beats GlaxoSmithKline (GSK)'s Advair in Trial 8/29/2012  More...
Bayer AG (BAY.F) Says Blood Thinner Cuts Risk of Repeat Heart Attack 8/29/2012  More...
The Medicines Company (MDCO) Release: Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin 8/28/2012  More...
AstraZeneca PLC (AZN) Release: New European Society of Cardiology Guidelines Recommend BRILINTA (Ticagrelor) in Acute Coronary Syndromes Patients With ST-Elevation 8/28/2012  More...
Daiichi Sankyo, Inc. (4568.t), Eli Lilly and Company (LLY) Say Heart Drug Effient Fails to Meet Goal in a Phase III Trial 8/27/2012  More...
Boehringer Ingelheim Corporation Release: Cost Effectiveness and Clinical Efficacy of Pradaxa® (Dabigatran Etexilate) Versus Rivaroxaban Analysed 8/24/2012  More...
Bionor Pharma ASA Release: Study of Vacc-4x Combined With Celgene (CELG)'s Revlimid® (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin 8/13/2012  More...
Pfizer Inc. (PFE)'s Torisel Drug Fails in a Combination Study 8/13/2012  More...
Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth 8/10/2012  More...
Bristol-Myers Squibb Company (BMY) & AstraZeneca PLC (AZN) Release: Pooled Analysis Showed Onglyza® (saxagliptin) Provided Improvements in Key Measures of Blood Sugar Control in Adults With Type 2 Diabetes at High Risk for CV Disease 7/30/2012  More...
Roche (RHHBY)'s Lucentis Works to Treat Vision Loss from Diabetes 7/25/2012  More...
AstraZeneca PLC (AZN) Starts New Study of Heart Drug Versus Rival 7/18/2012  More...
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test 7/11/2012  More...
Merck KGaA (MKGAF.PK) Says Erbitux Fails in Stomach Cancer Trial 7/6/2012  More...
Orexo AB Takes Large Step Forward on the Road to Improve Treatment for People Dependent on Opioid Pain Killers 7/2/2012  More...
Boehringer Ingelheim Corporation Release: No Significant Difference in the Risk of Acute Coronary Syndrome (including Myocardial Infarction) Seen With Pradaxa®(dabigatran etexilate) Compared to Enoxaparin for VTE Prevention After Orthopaedic Surgery 6/25/2012  More...
Genentech (RHHBY) Says Perjeta Combination Increased Survival in Breast Cancer Patients 6/22/2012  More...
FDA Staff Question Value of Sanofi (France) (SAN.PA) Blood Clot Drug 6/18/2012  More...
Sanofi (France) (SAN.PA) Announces Results of ORIGIN, the World's Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes 6/15/2012  More...
GlaxoSmithKline (GSK)'s Avandia and University of Nottingham's Actos are Linked to Vision Problems 6/13/2012  More...
New Epidemiological Data Provide Additional Safety Evidence for Sanofi (France) (SAN.PA)'s Lantus(R) 6/12/2012  More...
Alkermes plc (ALKS) Release: INVEGA® SUSTENNA® Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia 6/12/2012  More...
Sanofi (France) (SAN.PA)'s Lantus Shows No Cancer, Heart Risks: Study 6/12/2012  More...
Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival 6/12/2012  More...
Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia 6/11/2012  More...
Data From Follow-Up Study of Vertex Pharmaceuticals Incorporated (VRTX)' KALYDECO™ (ivacaftor) Showed Durable Improvements in Lung Function and Other Measures of Disease in People With Cystic Fibrosis Who Have a Specific Genetic Mutation (G551D) 6/8/2012  More...
Roche (RHHBY)'s Actemra Beats Abbott Laboratories (ABT) Drug in RA Trial 6/7/2012  More...
European Medicines Evaluation Agency Confirms Boehringer Ingelheim Corporation's Pradaxa Benefits, But Wants Clearer Guidance 5/25/2012  More...
Roche (RHHBY)'s Genentech (RHHBY) to Take Part in First-ever Alzheimer's Prevention Trial 5/21/2012  More...
Merck KGaA (MKGAF.PK)'s Erbitux Fails in Colon Cancer Study 5/9/2012  More...
Roche (RHHBY)'s Avastin and Novartis AG (NVS)'s Lucentis Equal for Treating Wet AMD - National Institutes of Health (NIH) Study 5/2/2012  More...
New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) (BIIB) & Biogen Idec, Inc. (Massachusetts) (BIIB) Commitment to Improving Outcomes in Multiple Sclerosis 4/27/2012  More...
Johnson & Johnson (JNJ) Alzheimer's Med Cut Chemical Tied to Brain Tangles 4/3/2012  More...
Servier's Protelos Effective Against Weak Bones 3/26/2012  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Complete Registrational Program for Relovair; Reports Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD 3/23/2012  More...
OncoGenex Pharmaceuticals Inc. Doubles Down on Prostate Cancer, as Competition Heats Up 3/12/2012  More...
Novartis AG (NVS) Cancer Drugs Fight Deadly Ebola Virus in Lab, Researchers Find 3/2/2012  More...
Roche (RHHBY)'s Zelboraf May Double Survival for Some Melanoma Patients 2/24/2012  More...
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma 2/23/2012  More...
European Medicines Evaluation Agency Recommends Lifting Suspension of Bayer HealthCare (BAY)'s Trasylol 2/21/2012  More...
AB Science (AB.PA) Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as Compared to Pfizer Inc. (PFE)'s Sutent®in Gleevec®-resistant GIST 2/1/2012  More...
Alkermes plc (ALKS) Initiates Open-Label Pilot Study of VIVITROL® to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence 1/31/2012  More...
Allos Therapeutics, Inc. (ALTH) Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at theEuropean Medicines Evaluation Agency 1/30/2012  More...
Roche (RHHBY)'s Avastin Fights Early Breast Cancer in 2 Studies: Will it be Re-approved? 1/27/2012  More...
GlaxoSmithKline (GSK)'s Dutasteride May Slow Low-Risk Prostate Cancer: Debate Heats Up 1/24/2012  More...
Roche (RHHBY) Melanoma Drug Spurs Growth of Other Skin Cancers: Study 1/20/2012  More...
Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study 1/19/2012  More...
Teva Pharmaceutical Industries Limited (TEVA) Release: Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE® 1/3/2012  More...
Roche (RHHBY)'s Avastin Disappoints Against Ovarian Cancer 1/3/2012  More...
Study Challenges Bristol-Myers Squibb Company (BMY) on Bristol-Myers Squibb Company (BMY) and Sanofi (France) (SAN.PA)'s Plavix 12/29/2011  More...
EarlySense Release: Studies Show that EarlySense’s Contact-Free Patient Monitoring System Effectively Helps Hospital Patients Avoid Pressure Ulcers 12/19/2011  More...
Clinuvel Announces Positive Results From Pivotal European Phase III Study: Endpoints Demonstrate Clinically Relevant Treatment Effect of Afamelanotide 12/19/2011  More...
Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline (GSK) Initiate Phase 3 Trial of Belimumab (BENLYSTA®) Administered Subcutaneously in Subjects with Systemic Lupus Erythematosus 12/15/2011  More...
Celgene International Sárl (CELG) Release: Final Phase II Data Evaluating REVLIMID® and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia 12/14/2011  More...
Celgene International Sárl (CELG) Release: Premiere Cooperative Group in Adult Lymphoma Research (GELA) Chooses REVLIMID® for Study in Second Most Common Lymphoma Subtype 12/14/2011  More...
Celgene International Sárl (CELG) Release: Phase III Study Evaluating REVLIMID® in Patients with High-Risk Smoldering Multiple Myeloma Presented at American Society of Hematology 12/14/2011  More...
Two Novartis AG (NVS) Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec® 12/13/2011  More...
Celgene International Sárl (CELG) Release: Final Data from Phase II Multi-Center Study Evaluating Combination of VIDAZA® and REVLIMID® in Higher-Risk MDS Patients Presented at American Society of Hematology 12/13/2011  More...
Celgene International Sárl (CELG) Release: REVLIMID® Evaluated in Combination with Rituximab as a Potential Treatment for Patients with Treatment-Naive Chronic Lymphocytic Leukemia 12/13/2011  More...
Celgene International Sárl (CELG) Release: Dosing Study Evaluates REVLIMID® in Previously Treated Patients with Chronic Lymphocytic Leukemia 12/12/2011  More...
Celgene International Sárl (CELG) Release: Results from a Comparative Analysis Shows REVLIMID® Demonstrates Statistically Significant Reduction in Risk of Death and No Evidence of Increased Risk of Progression to AML in Patients with Deletion 5q MDS Compared with Best Supportive Care 12/12/2011  More...
Roche (RHHBY) Absorbs New Setback for Avastin as Cancer Treatment 12/12/2011  More...
Latest Data on Novartis AG (NVS) Afinitor Confirms Efficacy 12/9/2011  More...
GlaxoSmithKline (GSK) Drug Fails to Hit Goal in Breast Cancer Trial 12/9/2011  More...
Boehringer Ingelheim Corporation,Eli Lilly and Company (LLY) Release: Linagliptin Demonstrates Meaningful Improvement in Glycaemic Control in Initial Combination Therapy with Metformin 12/8/2011  More...
Pooled Analysis: Fewer Major Adverse Cardiovascular Events in People with Type 2 Diabetes Treated with Merck Sharp & Dohme (MRK)'s JANUVIA ® (sitagliptin) 12/6/2011  More...
Novo Nordisk A/S (NVO) Release: Data Show That the Combination of Insulin Degludec/Insulin Aspart Significantly Reduced Hypoglycaemia in Type 1 and Type 2 Diabetes Patients 12/6/2011  More...
Regeneron Pharmaceuticals, Inc. (REGN)-Bayer HealthCare (BAY) Drug Matches Lucentis at 2 Years in Fewer Doses 12/6/2011  More...
Midatech Group Receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles 11/15/2011  More...
Sanofi (France) (SASY.PA)'s Multaq Doubled Deaths from Heart Disease in Study 11/15/2011  More...
The Medicines Company (MDCO) Release: German Researchers Reaffirm Utility of Angiomax(R)/Angiox(R) (Bivalirudin) in High Risk PCI Patients 11/14/2011  More...
Alkermes plc (ALKS) Release: New Long-Term Data on VIVITROL® Showed Sustained Efficacy and Safety over 18 Months of Treatment 11/9/2011  More...
Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer 11/9/2011  More...
Boehringer Ingelheim Corporation Release: Hepatitis C: Interferon-free Combination of BI 201335 Plus BI 207127 and ribavirin Shows up to 76% of Patients Achieve a Virological Response at Week 12, and 59% Achieve SVR12 with 16 Weeks Treatment 1 11/7/2011  More...
Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study 10/14/2011  More...
Novartis AG (NVS)' Onbrez Beats Boehringer Ingelheim Corporation/Pfizer Inc. (PFE)'s Spiriva for COPD Quality of Life 10/4/2011  More...
Merck & Co., Inc. (MRK), Sanofi (France) (SASY.PA) Cancer Vaccine Beats GlaxoSmithKline (GSK)'s Rival on Cost 9/29/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN) Release: Analyses Find Type 2 Diabetes Patients Treated with BYDUREON(TM) Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 9/12/2011  More...
National Institute for Clinical Excellence (NICE) Questions Merck & Co., Inc. (MRK), Nycomed COPD Drug 9/12/2011  More...
AstraZeneca PLC (AZN)'s Crestor Fails to Beat Pfizer Inc. (PFE)'s Lipitor 9/6/2011  More...
Head-to-Head Data on AstraZeneca PLC (AZN)'s Crestor Vs. Pfizer Inc. (PFE)'s Lipitor Results Due Soon 8/31/2011  More...
AstraZeneca PLC (AZN) Bloodthinner Shows Mortality Benefit Versus Sanofi (France) (SASY.PA)'s Plavix 8/30/2011  More...
GlaxoSmithKline (GSK) HPV Vaccine Protects Women From Anal Cancer 8/24/2011  More...
Roche (RHHBY)'s Herceptin Has Higher Heart Risk for Older Women 8/10/2011  More...
Roche (RHHBY) Cancer Drug Rejected by National Institute for Clinical Excellence (NICE) Found to Triple Survival Time 7/26/2011  More...
Bayer AG (BAY.F)'s Xarelto Blood Thinner Matched Warfarin in Japanese Safety Study 7/25/2011  More...
Sanofi (France) (SASY.PA) Halts Clinical Trial of Heart Drug Multaq 7/7/2011  More...
AstraZeneca PLC (AZN)'s Brilinta Worse With High-Dose Aspirin in Analysis 6/29/2011  More...
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study 6/29/2011  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos, GlaxoSmithKline (GSK)'s Avandia Raise Risk of Eye Disease 6/27/2011  More...
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study 6/14/2011  More...
FDA Reviews Blood Clot Risk with Bayer Corporation (BAY) Contraceptives 6/1/2011  More...
Avastin Likely Will be Approved for Ovarian Cancer, Roche Holding AG (RHHBF.PK) Says 5/27/2011  More...
Bayer AG (BAY.F), Johnson & Johnson (JNJ)’s Xarelto Prevented Repeat Strokes in Analysis 5/25/2011  More...
Pfizer Inc. (PFE): Adding Inspra(R) (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows 5/23/2011  More...
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study 5/20/2011  More...
Crohn's Patients Respond to Johnson & Johnson (JNJ)'s Stelara in Study 5/9/2011  More...
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study 5/2/2011  More...
Extended-Release Naltrexone Can Be Used In Opioid Addicts; But Linked Comment Authors Criticise FDA For Ever Having Approved The Drug 4/28/2011  More...
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study 4/6/2011  More...
Merck Serono: Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU 3/30/2011  More...
Boehringer Ingelheim Corporation: Dabigatran Etexilate is Cost-Effective for Stroke Prevention in Atrial Fibrillation 3/24/2011  More...
Novartis AG, Roche (RHHBY)’s Xolair Blunts Asthma Attacks in Children in U.S. Cities 3/17/2011  More...
Elan Corporation PLC (ELN), Biogen Idec, Inc. (Massachusetts) (BIIB) Tysabri Reports 10 More Brain Disease Cases 2/22/2011  More...
Novartis AG's Onbrez Plus Rival, Pfizer Inc. (PFE)'s Drug Boosts Lung Function 2/10/2011  More...
Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference 12/9/2010  More...
Pierre Fabre's Bladder Cancer Drug, Javlor too Costly for National Health Service, National Institute for Clinical Excellence (NICE) Says 11/23/2010  More...





 

//-->